Safety of human neural stem cell transplantation in chronic spinal cord injury

Stem Cells Translational Medicine

Volumn 2, Issue 12, 2013, Pages 961-974

  Piltti, Katja M ^a   Salazar, Desiree L ^a,b   Uchida, Nobuko ^c   Cummings, Brian J ^a   Anderson, Aileen J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c StemCells Inc   (United States)

Author keywords

CGRP; Chronic transplantation; Fate; Mechanical allodynia; Migration; Neural stem cell; Spinal cord injury; Thermal hyperalgesia

Indexed keywords

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; NEURAL STEM CELL TRANSPLANTATION; NOCICEPTION; NONHUMAN; OLIGODENDROGLIA; RAT; SPINAL CORD INJURY;

ANIMALIA; RATTUS;

EID: 84888415260     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2013-0064     Document Type: Article

References (93)

1. Wyndaele M, Wyndaele JJ. Incidence, prevalence and epidemiology of spinal cord injury: What learns a worldwide literature survey? Spinal Cord 2006;44:523-529.
2. van den Berg M, Castellote J, Mahillo-Fernandez I et al. Incidence of spinal cord injury worldwide: A systematic review. Neuroepidemiology; 34:184.
3. Devivo M. Epidemiology of traumatic spinal cord injury: Trends and future implications. Spinal Cord 2012;50:365-372.
4. Cummings BJ, Uchida N, Tamaki SJ et al. Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice. Proc Natl Acad Sci USA 2005;102: 14069-14074.
5. Hooshmand MJ, Sontag CJ, Uchida N et al. Analysis of host-mediated repair mechanisms after human CNS-stem cell transplantation for spinal cord injury: Correlation of engraftment with recovery. PLoS One 2009;4:e5871.
6. Salazar DL, Uchida N, Hamers FP et al. Human neural stem cells differentiate and promote locomotor recovery in an early chronic spinal cord injury NOD-scid mouse model. PLoS One 2010;5:e12272.
7. Piltti KM, Salazar DL, Uchida N et al. Safety of epicenter versus intact parenchyma as a transplantation site for human neural stem cells for spinal cord injury therapy. STEM CELLS TRANSLATIONAL MEDICINE 2013;2:204-216.
8. Tetzlaff W, Okon E, Karimi-Abdolrezaee S et al. A systematic review of cellular transplantation therapies for spinal cord injury. J Neurotrauma 2011;28:1611-1682.
9. Fawcett J, Curt A, Steeves J et al. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: Spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials. Spinal Cord 2007;45:190-205.
10. Srinivas TR, Meier-Kriesche H-U. Minimizing immunosuppression, an alternative approach to reducing side effects: Objectives and interim result. Clin J Am Soc Nephrol 2008; 3(suppl 2):S101-S116.
11. Cummings BJ, Hooshmand MJ, Salazar DL et al. Human neural stem cell mediated repair of the contused spinal cord: Timing the microenvironment. In: Ribak CE, Ara'mburo de la Hoz C, Jones EG et al., eds. From Development to Degeneration and Regeneration of the Nervous System. Oxford, U.K.: Oxford University Press, 2009:297-322.
12. Houle J, Tessler A. Repair of chronic spinal cord injury. Exp Neurol 2003;182:247-260.
13. Basso D, Beattie M, Bresnahan J. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 1995; 12:1-21.
14. Hill C, Beattie M, Bresnahan J. Degeneration and sprouting of identified descending supraspinal axons after contusive spinal cord injury in the rat. Exp Neurol 2001;171:153-169.
15. Anderson A. Mechanisms and pathways of inflammatory responses in CNS trauma: Spinal cord injury. J Spinal Cord Med 2002;25:70.
16. Jones T, McDaniel E, Popovich P. Inflammatory-mediated injury and repair in the traumatically injured spinal cord. Curr Pharm Des 2005;11:1223-1236.
17. Popovich P, Jones T. Manipulating neuroinflammatory reactions in the injured spinal cord: Back to basics. Trends Pharmacol Sci 2003;24:13-17.
18. Schwartz M, Butovsky O, Bruck, W et al. Microglial phenotype: Is the commitment reversible? Trends Neurosci 2006;29:68-74.
19. Kigerl K, McGaughy V, Popovich P. Comparative analysis of lesion development and intraspinal inflammation in four strains of mice following spinal contusion injury. J Comp Neurol 2006;494:578-594.
20. Beck KD, Nguyen HX, Galvan MD et al. Quantitative analysis of cellular inflammation after traumatic spinal cord injury: Evidence for a multiphasic inflammatory response in the acute to chronic environment. Brain 2010;133: 433-447.
21. Chow S, Moul J, Tobias C et al. Characterization and intraspinal grafting of EGF/bFGFdependent neurospheres derived from embryonic rat spinal cord. Brain Res 2000;874: 87-193.
22. Cao Q, Zhang Y, Howard R et al. Pluripotent stem cells engrafted into the normal or lesioned adult rat spinal cord are restricted to a glial lineage. Exp Neurol 2001;167:48-106.
23. Macias M, Syring M, Pizzi M et al. Pain with no gain: Allodynia following neural stem cell transplantation in spinal cord injury. Exp Neurol 2006;201:335-383.
24. Kumamaru H, Kobayakawa K, Saiwai H et al. The therapeutic activities of engrafted neural stem/precursor cells are not dormant in the chronically injured spinal cord. STEM CELLS 2013; 31:1535-1547.
25. Hargreaves K, Dubner R, Brown F et al. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988;32:77-165.
26. Hains B, Johnson K, Eaton M et al. Serotonergic neural precursor cell grafts attenuate bilateral hyperexcitability of dorsal horn neurons after spinal hemisection in rat. Neuroscience 2003;116:1097-1207.
27. Horiuchi H, Ogata T, Morino T et al. Adenosine A1 receptor agonists reduce hyperalgesia after spinal cord injury in rats. Spinal Cord 2010;48:685-690.
28. Gabriel A, Marcus M, Honig WM et al. The CatWalk method: A detailed analysis of behavioral changes after acute inflammatory pain in the rat. J Neurosci Methods 2007;163: 9-25.
29. Vrinten D, Hamers F. "CatWalk" automated quantitative gait analysis as a novel method to assess mechanical allodynia in the rat: A comparison with von Frey testing. Pain 2003;102:203-212.
30. Uchida N, Buck DW, He D et al. Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci USA 2000;97: 14720-14725.
31. Hamers F, Koopmans G, Joosten E. Cat-Walk-assisted gait analysis in the assessment of spinal cord injury. J Neurotrauma 2006;23: 537-548.
32. Muja N, Cohen M, Zhang J et al. Neural precursors exhibit distinctly different patterns of cell migration upon transplantation during either the acute or chronic phase of EAE: A serialMRimaging study. Magn Reson Med. 2011; 65:1738-1749.
33. Potas J, Zheng Y, Moussa C et al. Augmented locomotor recovery after spinal cord injury in the athymic nude rat. J Neurotrauma 2006;23:660-673.
34. Gorrie C, Hayward I, Cameron N et al. Effects of human OEC-derived cell transplants in rodent spinal cord contusion injury. Brain Res 2010;1337:8-20.
35. Rabchevsky A, Fugaccia I, Sullivan P et al. Efficacy of methylprednisolone therapy for the injured rat spinal cord. J Neurosci Res 2002;68: 7-18.
36. Sugimori M, Nagao M, Parras C et al. Ascl1 is required for oligodendrocyte development in the spinal cord. Development 2008; 135:1271-1281.
37. Zhu X, Zuo H, Maher B et al. Olig2-dependent developmental fate switch of NG2 cells. Development 2012;139:2299-2307.
38. Carlton S, McNeill D, Chung K et al. A light and electron microscopic level analysis of calcitonin gene-related peptide (CGRP) in the spinal cord of the primate: An immunohistochemical study. Neurosci Lett 1987;82:145-150.
39. Ackery A, Norenberg M, Krassioukov A. Calcitonin gene-related peptide immunoreactivity in chronic human spinal cord injury. Spinal Cord 2007;45:678-686.
40. Ondarza A, Ye Z, Hulsebosch C. Direct evidence of primary afferent sprouting in distant segments following spinal cord injury in the rat: Colocalization of GAP-43 and CGRP. Exp Neurol 2003;184:373-380.
41. Finnerup N. Pain in patients with spinal cord injury. Pain 2012, 10.1016/j. pain.2012. 12.007.
42. Davies J, Pröschel C, Zhang N et al. Transplanted astrocytes derived from BMP-or CNTF-treated glial-restricted precursors have opposite effects on recovery and allodynia after spinal cord injury. J Biol 2008;7:24.
43. Hofstetter C, Schwarz E, Hess D et al. Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc Natl Acad Sci USA 2002;99:2199-2403.
44. Calmels P, Mick G, Perrouin-Verbe B et al. Neuropathic pain in spinal cord injury: Identification, classification, evaluation. Ann Phys Rehabil Med 2009;52:83-185.
45. Christensen M, Hulsebosch C. Chronic central pain after spinal cord injury. J Neurotrauma 1997;14:517-537.
46. Moalem G, Xu K, Yu L. T lymphocytes play a role in neuropathic pain following peripheral nerve injury in rats. Neuroscience 2004;129: 767-777.
47. Cao L, DeLeo J. CNS-infiltrating CD4_ T lymphocytes contribute to murine spinal nerve transection-induced neuropathic pain. Eur J Immunol 2008;38:448-458.
48. Costigan M, Moss A, Latremoliere A et al. T-cell infiltration and signaling in the adult dorsal spinal cord is a major contributor to neuropathic pain-like hypersensitivity. J Neurosci 2009;29:14415-14422.
49. Liu H, Shiryaev S, Chernov A et al. Immunodominant fragments of myelin basic protein initiate T cell-dependent pain. J Neuroinflamm 2012;9:119.
50. Hamers F, Lankhorst A, van Laar T et al. Automated quantitative gait analysis during overground locomotion in the rat: Its application to spinal cord contusion and transection injuries. J Neurotrauma 2001;18:187-201.
51. Eaton M, Pearse D, McBroom J et al. The combination of human neuronal serotonergic cell implants and environmental enrichment after contusive SCI improves motor recovery over each individual strategy. Behav Brain Res 2008;194:236-241.
52. Karimi-Abdolrezaee S, Eftekharpour E, Wang J et al. Delayed transplantation of adult neural precursor cells promotes remyelination and functional neurological recovery after spinal cord injury. J Neurosci 2006;26:3377-3389.
53. Keirstead HS, Nistor G, Bernal G et al. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci 2005;25:4694-4705.
54. Pfeifer K, Vroemen M, Caioni M et al. Autologous adult rodent neural progenitor cell transplantation represents a feasible strategy to promote structural repair in the chronically injured spinal cord. Regen Med 2006;1:255-266.
55. Anderson A, Haus D, HooshmandMet al. Achieving stable human stem cell engraftment and survival in the CNS: Is the future of regenerative medicine immunodeficient? Regen Med 2011;6:367-773.
56. Martino G, Pluchino S, Bonfanti L et al. Brain regeneration in physiology and pathology: The immune signature driving therapeutic plasticity of neural stem cells. Physiol Rev 2011;91:1281-1304.
57. Kokaia Z, Martino G, Schwartz M et al. Cross-talk between neural stem cells and immune cells: The key to better brain repair? Nat Neurosci 2012;15:1078-1087.
58. Sharma M, Afrin F, Satija N et al. Stromalderived factor-1/CXCR4 signaling: Indispensable role in homing and engraftment of hematopoietic stem cells in bone marrow. Stem Cells Dev 2011;20:933-946.
59. Bouchentouf M, Benabdallah B, Bigey P et al. Vascular endothelial growth factor reduced hypoxia-induced death of human myoblasts and improved their engraftment in mouse muscles. Gene Ther 2008;15:404-414.
60. Anderson AJ, Robert S, Huang W et al. Activation of complement pathways after contusion-induced spinal cord injury. J Neurotrauma 2004;21:1831-1846.
61. Monje M, Toda H, Palmer T. Inflammatory blockade restores adult hippocampal neurogenesis. Science 2003;302:1760-1765.
62. Mocchetti I, Wrathall J. Neurotrophic factors in central nervous system trauma. J Neurotrauma 1995;12:853-870.
63. Bareyre F, Schwab M. Inflammation, degeneration and regeneration in the injured spinal cord: Insights from DNA microarrays. Trends Neurosci 2003;26:555-563.
64. Blight A, Young W. Central axons in injured cat spinal cord recover electrophysiological function following remyelination by Schwann cells. J Neurol Sci 1989;91:15-34.
65. Powers B, Lasiene J, Plemel J et al. Axonal thinning and extensive remyelination without chronic demyelination in spinal injured rats. J Neurosci 2012;32:5120-5125.
66. Powers B, Sellers D, Lovelett E et al. Remyelination reporter reveals prolonged refinement of spontaneously regenerated myelin. Proc Natl Acad Sci USA 2013;110:4075-4080.
67. Lasiene J, Shupe L, Perlmutter S et al. No evidence for chronic demyelination in spared axons after spinal cord injury in a mouse. J Neurosci 2008;28:3887-3896.
68. Jiang J, Papoutsakis E. Stem-cell niche based comparative analysis of chemical and nano-mechanical material properties impacting ex vivo expansion and differentiation of hematopoietic and mesenchymal stem cells. Adv Healthc Mater 2013;2:25-42.
69. Voog J, Jones D. Stem cells and the niche: A dynamic duo. Cell Stem Cell 2010;6:103-115.
70. Zhang J, Niu C, Ye L et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 2003;425:836-841.
71. Sontag CJ, Uchida N, Cummings BJ et al. The injured spinal cord niche alters the engraftment dynamics of human neural stem cells. Stem Cell Rep 2013 (in press).
72. Hofstetter C, Holmström N, Lilja J et al. Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome. Nat Neurosci 2005;8:346-399.
73. Cirillo G, De Luca D, Papa M. Calcium imaging of living astrocytes in the mouse spinal cord following sensory stimulation. Neural Plast 2012;2012:425818.
74. Takatsuru Y, Eto K, Kaneko R et al. Critical role of the astrocyte for functional remodeling in contralateral hemisphere of somatosensory cortex after stroke. J Neurosci 2013;33:4683-4692.
75. Jin Y, Neuhuber B, Singh A et al. Transplantation of human glial restricted progenitors and derived astrocytes into a contusion model of spinal cord injury. J Neurotrauma 2011;28:579-594.
76. Eftekharpour E, Karimi-Abdolrezaee S, Fehlings M. Current status of experimental cell replacement approaches to spinal cord injury. Neurosurg Focus 2008;24:E19.
77. Guest J, Hiester E, Bunge R. Demyelination and Schwann cell responses adjacent to injury epicenter cavities following chronic human spinal cord injury. Exp Neurol 2005;192: 384-393.
78. Nashmi R, Fehlings M. Changes in axonal physiology and morphology after chronic compressive injury of the rat thoracic spinal cord. Neuroscience 2001;104:235-251.
79. Nori S, Okada Y, Yasuda A et al. Grafted human-induced pluripotent stem-cell-derived neurospheres promote motor functional recovery after spinal cord injury in mice. Proc Natl Acad Sci USA 2011;108:16825-16830.
80. Tsuji O, Miura K, Okada Y et al. Therapeutic potential of appropriately evaluated safeinduced pluripotent stem cells for spinal cord injury. Proc Natl Acad Sci USA 2010;107: 12704-12709.
81. Tamaki S, Jacobs Y, Dohse M et al. Neuroprotection of host cells by human central nervous system stem cells in a mouse model of infantile neuronal ceroid lipofuscinosis. Cell Stem Cell 2009;5:310-319.
82. Uchida N, Chen K, DohseMet al. Human neural stem cells induce functional myelination in mice with severe dysmyelination. Sci Transl Med 2012;4:155ra136.
83. Gledhill R, Harrison B, McDonald W. Demyelination and remyelination after acute spinal cord compression. Exp Neurol 1973;38: 472-487.
84. Harrison B, McDonald W. Remyelination after transient experimental compression of the spinal cord. Ann Neurol 1977;1: 542-551.
85. Salgado-Ceballos H, Guizar-Sahagun G, Feria-Velasco A et al. Spontaneous long-term remyelination after traumatic spinal cord injury in rats. Brain Res 1998;782:126-135.
86. Smith P, Jeffery N. Histological and ultrastructural analysis of white matter damage after naturally-occurring spinal cord injury. Brain Pathol 2006;16:99-109.
87. Arvanian V, Schnell L, Lou L et al. Chronic spinal hemisection in rats induces a progressive decline in transmission in uninjured fibers to motoneurons. Exp Neurol 2009;216:471-480.
88. Baptiste D, Fehlings M. Pharmacological approaches to repair the injured spinal cord. J Neurotrauma 2006;23:318-334.
89. Bunge R, Puckett W, Becerra J et al. Observations on the pathology of human spinal cord injury. A review and classification of 22 new cases with details from a case of chronic cord compression with extensive focal demyelination. Adv Neurol 1993;59:75-89.
90. Hunanyan A, Alessi V, Patel S et al. Alterations of action potentials and the localization of Nav1.6 sodium channels in spared axons after hemisection injury of the spinal cord in adult rats. J Neurophysiol 2011;105:1033-1044.
91. Totoiu M, Keirstead H. Spinal cord injury is accompanied by chronic progressive demyelination. J Comp Neurol 2005;486: 373-383.
92. Sontag CJ, Nguyen HX, Kamei N et al. Immunosuppressants affect human neural stem cells in vitro but not in an in vivo model of spinal cord injury. STEM CELLS TRANSLATIONALMEDICINE 2013;2:731-744.
93. Basso D, Beattie M, Bresnahan J. Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp Neurol 1996; 139:244-256.